04:33 PM EST, 01/21/2026 (MT Newswires) -- Jeffrey Bluestone, Director, on January 20, 2026, sold 5,000 shares in Gilead Sciences ( GILD ) for $617,500. Following the Form 4 filing with the SEC, Bluestone has control over a total of 8,920 common shares of the company, with 8,920 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/882095/000177181426000002/xslF345X05/wk-form4_1769030768.xml